Epidermal Growth Factor Receptor Polymorphisms and Risk for Toxicity in Paediatric Patients Treated With Gefitinib

European Journal of Cancer - United Kingdom
doi 10.1016/j.ejca.2010.05.007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Effect of Epidermal Growth Factor Receptor Gene Polymorphisms on Prognosis in Glioma Patients

Oncotarget
Oncology
2016English

The Association Between Epidermal Growth Factor Receptor (EGFR) Gene Polymorphisms and Lung Cancer Risk

Biomolecules
BiochemistryMolecular Biology
2018English

Gefitinib Induces Epidermal Growth Factor Receptor Dimers Which Alters the Interaction Characteristics With 125i-Egf

PLoS ONE
Multidisciplinary
2011English

Gefitinib-Induced Cardiomyopathy in Epidermal Growth Receptor-Mutated NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Autophagic Degradation of Epidermal Growth Factor Receptor in Gefitinib-Resistant Lung Cancer by Celastrol

International Journal of Oncology
Cancer ResearchOncology
2016English

Improving Therapy for Patients With Epidermal Growth Factor Receptor-Mutant Lung Cancer

Cancer
Cancer ResearchOncology
2018English

Symmetrical Drug-Related Intertriginous and Flexural Exanthema Secondary to Epidermal Growth Factor Receptor Inhibitor Gefitinib

JAAD Case Reports
Dermatology
2020English

Epidermal Growth Factor Receptor Mutation as a Risk Factor for Recurrence in Lung Adenocarcinoma

Annals of Thoracic Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2018English

Epidermal Growth Factor Receptor Activity Determines Response of Colorectal Cancer Cells to Gefitinib Alone and in Combination With Chemotherapy

Clinical Cancer Research
Cancer ResearchOncology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy